Nutra Pharma reported revenue of $0.00B and net income of -$0.00B for the quarter ended Jun 2026, down 59.2% year over year. This income statement covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jun2010 | Sep2010 | Dec2010 | Mar2011 | Jun2011 | Sep2011 | Dec2011 | Mar2012 | Jun2012 | Sep2012 | Dec2012 | Mar2013 | Jun2013 | Sep2013 | Dec2013 | Mar2014 | Jun2014 | Sep2014 | Dec2014 | Mar2015 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Revenue | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | |||||||||||||||||||||||||||||||||||||||||||||
| Cost of RevenueCost of Rev | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | |||||||||||||||||||||||||||||||||||||||||||||
| Gross Profit | 0.00B | -0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | -0.00B | 0.00B | 0.00B | |||||||||||||||||||||||||||||||||||||||||||||
| Operating items | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Selling, General & AdministrativeSG&A | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | ||||||||||||||||||||||||||||||||||||||||||||||||
| Restructuring CostsRestructuring | 0.00B | 0.00B | 0.00B | 0.00B | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Operating ExpensesOther Opex | -0.00B | 0.00B | 0.00B | -0.00B | 0.00B | 0.00B | -0.00B | -0.00B | 0.00B | 0.00B | 0.00B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Operating ExpensesOpex | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | |||||||||||||||||||||||||||||||||||||||||||||
| Operating IncomeOp. Inc | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | |||||||||||||||||||||||||||||||||||||||||||||
| EBIT | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | |||||||||||||||||||||||||||||||||||||||||||||
| Non-operating items | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | |||||||||||||||||||||||||||||||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | -0.00B | 0.00B | 0.00B | -0.00B | 0.00B | 75.00 | 900.00 | 0.00B | -0.00B | -0.00B | 0.00B | -0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | |||||||||||||||||||||||||||||||||||||||||||||||
| Non Operating IncomeNon Op. Inc. | 0.02B | 0.00B | 0.01B | -0.00B | 0.00B | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | |||||||||||||||||||||||||||||||||||||||||||||
| Net income details | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EBT | 0.02B | 0.00B | 0.01B | -0.00B | 0.00B | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | |||||||||||||||||||||||||||||||||||||||||||||
| Profit After TaxPAT | 0.02B | 0.00B | 0.01B | -0.00B | 0.00B | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | |||||||||||||||||||||||||||||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | 0.02B | 0.00B | 0.01B | -0.00B | 0.00B | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | |||||||||||||||||||||||||||||||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | 0.02B | 0.00B | 0.01B | -0.00B | 0.00B | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | |||||||||||||||||||||||||||||||||||||||||||||
| Income towards Parent CompanyParent Net Inc | 0.01B | 0.00B | 0.00B | -0.00B | -0.00B | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | |||||||||||||||||||||||||||||||||||||||||||||
| Net Income towards Common StockholdersNet Income | 0.01B | 0.00B | 0.00B | -0.00B | -0.00B | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | |||||||||||||||||||||||||||||||||||||||||||||
| Additional items | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS (Basic) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||
| EPS (Diluted) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||
| Shares Outstanding | 7.29B | 7.23B | 7.35B | 7.47B | 7.59B | 7.50B | 7.60B | 7.60B | 7.61B | 7.61B | 7.64B | 7.66B | 7.66B | 7.67B | 7.68B | 7.74B | 7.82B | 7.78B | 8.01B | 8.07B | |||||||||||||||||||||||||||||||||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 12.67B | 7.23B | 14.50B | 7.47B | 15.60B | 19.10B | 7.60B | 7.60B | 7.61B | 7.61B | 7.64B | 7.66B | 7.66B | 7.67B | 7.68B | 37.73B | 7.82B | 7.78B | 8.01B | 8.07B | |||||||||||||||||||||||||||||||||||||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 7.31B | 7.33B | 7.36B | 7.59B | 7.60B | 7.04B | 7.04B | 7.04B | 7.06B | 7.06B | 7.06B | 7.10B | 7.10B | 7.10B | 7.10B | 7.10B | 7.10B | 7.10B | 7.16B | 7.16B | |||||||||||||||||||||||||||||||||||||||||||||
| EBITDA | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | |||||||||||||||||||||||||||||||||||||||||||||
| Interest ExpensesInt Expense | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B |